Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(NY: ELV )

410.89 -2.03 (-0.49%)
Official Closing Price Updated: 7:00 PM EST, Nov 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ELV

< Previous 1 2 3 4 5 6 7 8 9 Next >
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Exposures Political
Breaking Down Elevance Health: 15 Analysts Share Their Views
Via Benzinga
What You Missed On Wall Street This Past Friday
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 
Via Talk Markets
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 15 Years
Via Benzinga
Decoding 11 Analyst Evaluations For Elevance Health
Via Benzinga
These Analysts Cut Their Forecasts On Elevance Health Following Q3 Earnings
Via Benzinga
Analyst Ratings For Elevance Health
Via Benzinga
What the Earnings Miss Means For Elevance’s Future
A discussion about how you should react and how you should handle earnings announcements, especially when they are negative. 
Via Talk Markets
Topics Earnings
Exposures Financial
Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key
Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled. 
Via Investor's Business Daily
NIO, ASML, And CVS Health Are Among Top 10 Large Cap Losers Last Week (Oct 14-18): Are The Others In Your Portfolio?
10 worst performing stocks last week: NIO -16.35%, KLAC -15.58%, CNC -14.38%, Elevance -14.17%, ASML -13.97%, PDD -13.91%, MOH -12.24%, LRCX -12.12%, ERIE -9.92%, CVS -9.44% 
Via Benzinga
Elevance, CVS, UnitedHealth Struggle With Rising Medical Costs After COVID-19 Medicaid Policy Ends
Insurers have reported higher medical costs due to the end of pandemic-era policies. States redetermining Medicaid eligibility created a disparity for insurers. 
Via Benzinga
Exposures COVID-19
A Look Ahead: Elevance Health's Earnings Forecast
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $4,200 Today
Via Benzinga
Here's How Much You Would Have Made Owning Elevance Health Stock In The Last 20 Years
Via Benzinga
Decoding Elevance Health's Options Activity: What's the Big Picture?
Via Benzinga
Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review
The Dow Jones and S&P 500 hit highs as they extended weekly win streaks. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Why Is Elevance Health Stock Trading Lower On Thursday?
Evolent Health stock reacted negatively amid Elevance Health's mixed results and Medicaid utilization pressures. 
Via Benzinga
Elevance Health (ELV) Q3 2024 Earnings Call Transcript
ELV earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
AI Chip Manufacturer Breaks Out – Nvidia May Be Next, Consumer Splurges, Fed Spiked The Punch
To gain an edge, this is what you need to know today. 
Via Benzinga
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
$100 Invested In Elevance Health 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Looking Into Elevance Health's Recent Short Interest
Via Benzinga
13 Analysts Have This To Say About Elevance Health
Via Benzinga
Chipmakers Rally, Nvidia Smashes Records On TSMC Blowout Earnings, Gold Hit All-Time Highs: What's Driving Market Thursday?
A semiconductor rally pushed the S&P 500 to new all-time highs on Thursday, with strong earnings from Taiwan Semiconductor Manufacturing Co. Ltd. 
Via Benzinga
Elevance Health's Q3 Earnings: Profit Falls Short Of Expectations On Higher Medical Costs, Issues Soft Annual Outlook
Elevance Health reported Q3 revenue of $44.7 billion, driven by higher premium yields and CarelonRx growth. However, profit fell 21%, and adjusted EPS missed expectations. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Elevance Health (ELV) Shares Are Falling
Elevance Health shares edged lower by 3.5% on Tuesday. Healthcare stocks are trading lower following UnitedHealth Group's Q3 earnings report. 
Via Benzinga
UnitedHealth Beats But Reins In Outlook As Costs Rise; UNH Stock Slips
The Dow giant's Optum services unit generated over 50% of operating income. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Humana Stock Dives On Medicare Ratings; UnitedHealth Tries To Bounce
Humana Medicare Advantage plans are getting a big star-ratings cut. 
Via Investor's Business Daily
Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms
Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.